Adebrelimab Combined With Oral Etoposide for Elderly Patients and Patients With Poor Performance Status in Small Cell Lung Cancer: An Exploratory Clinical Study

This is a multicenter, single-arm, exploratory clinical study designed to observe and evaluate the efficacy and safety of adebrelimab combined with oral etoposide for elderly patients and patients with poor performance status in small cell lung cancer.

NCT Number	NCT07398560
Lead Sponsor	The Third Affiliated Hospital of Harbin Medical University
Conditions	Small Cell Lung Cancer
Enrollment	47 participants
Start Date	2026-02-01
Primary Completion	2028-02-01 (estimated)
Study Completion	2029-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-02-10